by Matt Neal
In what may be one of the most niche topics for a podcast, Operations Utopia is a podcast about the desperate need to streamline Life Sciences Operations to get treatments to patients faster and explores how life sciences organizations should operate—by examining why they usually don’t. Disclaimer: The podcast content represents the opinion of the speakers, guests & host and does not reflect those of their organizations, system vendors, or service providers.
Language
🇺🇲
Publishing Since
4/24/2026
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
July 3, 2026
Something meaningfully different has happened in the last few weeks — and Paul Slater is one of the few people talking about it in a way that goes past the hype. Paul is a two-decade Microsoft veteran (where he defined the company's Life Sciences strategy), current Adobe thought leader, author of The AI-Ready Human, and host of the Humanity Working podcast. When he says he just built a hybrid CRM / CMS / news feed for his own job in twelve hours using Claude Code, it isn't a party trick. It's a signal. Matt and Paul spend an hour on what that signal means. The new frontier isn't asking Claude for help; it's vibe coding the perfect workflow for whatever job you have. They get into why every commercial product is an artifact of cost to market, not necessity — and why the product becomes the problem. What survives from the standard-software stack in regulated industries. Why companies like Veeva and Salesforce may need to reinvent themselves as role-enablement layers. And the reason for both Paul's morning "we're all screwed" moments and his afternoon "this is enormous work" ones: almost nothing about how we structure work is fit for purpose.
June 19, 2026
Nuno Valério is Head of Innovation, R&D Quality at Merck, based in Germany. With 11+ years in pharma quality across deviations, audits, and observations, plus an active public-facing practice on AI governance, Nuno has become a distinctive voice on what trustworthy AI looks like inside a regulated R&D organization. He writes and speaks regularly on a framework he calls trust architecture — a multi-dimensional approach to validating not the model itself but the workflow, guardrails, and human-machine ecosystem around it. He's a featured speaker at the 2026 Clinical Trial Innovation Summit in Basel, where his session focuses on designing AI governance from both sides of the wall — pharma and regulator — drawing on his hands-on work at Merck.
June 12, 2026
Few people have lived through more change cycles in regulatory operations than Scott Cleve. Across 20+ years at Accenture, AbbVie, Astellas, Boehringer Ingelheim, bluebird bio, and now Daiichi Sankyo, Scott has built and led global Reg Ops organizations through wave after wave of new technology — and figured out a few things about how change actually sticks. Matt and Scott trace the arc from a 2017 Alexa pilot at Boehringer Ingelheim (RIP — voice capture for affiliate correspondence) to today's reality of AI agents working alongside humans as teammates. Along the way: the three obstacles that quietly slow every change initiative, why "training" a workforce two weeks before go-live with a PowerPoint is the corporate equivalent of asking a kid to play in the World Cup, and the backhanded compliment that defines a great Reg Ops team — you guys do your job so well, I don't even think about it.
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
In what may be one of the most niche topics for a podcast, Operations Utopia is a podcast about the desperate need to streamline Life Sciences Operations to get treatments to patients faster and explores how life sciences organizations should operate—by examining why they usually don’t.
Disclaimer: The podcast content represents the opinion of the speakers, guests & host and does not reflect those of their organizations, system vendors, or service providers.
This podcast updates daily.
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
Yes, this podcast regularly features guests.
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.